Literature DB >> 24333294

O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis.

L Tardio1, J Andrés-Bergós1, N E Zachara2, A Larrañaga-Vera1, C Rodriguez-Villar3, G Herrero-Beaumont1, R Largo4.   

Abstract

OBJECTIVE: There is increasing evidence that the addition of O-linked N-acetylglucosamine (O-GlcNAc) to proteins plays an important role in cell signaling pathways. In chondrocytes, accumulation of O-GlcNAc-modified proteins induces hypertrophic differentiation. Osteoarthritis (OA) is characterized by cartilage degradation, and hypertrophic-like changes in hyaline chondrocytes. However, the mechanisms responsible for these changes have not been described. Our aim was to study whether O-GlcNAcylation and the enzymes responsible for this modification are dysregulated in the cartilage of patients with knee OA and whether interleukin-1 could induce these modifications in cultured human OA chondrocytes (HOC).
DESIGN: Human cartilage was obtained from patients with knee OA and from age and sex-matched healthy donors. HOC were cultured and stimulated with the catabolic cytokine IL-1α. Global protein O-GlcNAcylation and the synthesis of the key enzymes responsible for this modification, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), were assessed by western blot.
RESULTS: OA was associated with a 4-fold increase in the global O-GlcNAcylation in the cartilage. OA cartilage showed a re-distribution of the OGT and OGA isoforms, with a net increase in the presence of both enzymes, in comparison to healthy cartilage. In HOC, IL-1α stimulation rapidly increased O-GlcNAcylation and OGT and OGA synthesis.
CONCLUSIONS: Our results indicate that a proinflammatory milieu could favor the accumulation of O-GlcNAcylated proteins in OA cartilage, together with the dysregulation of the enzymes responsible for this modification. The increase in O-GlcNAcylation could be responsible, at least partially, for the re-expression of hypertrophic differentiation markers that have been observed in OA.
Copyright © 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage; Chondrocytes; Glycosylation; Hypertrophic differentiation; O-GlcNAcylation

Mesh:

Substances:

Year:  2013        PMID: 24333294     DOI: 10.1016/j.joca.2013.12.001

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  12 in total

1.  Elevation of α-1,3 fucosylation promotes the binding ability of TNFR1 to TNF-α and contributes to osteoarthritic cartilage destruction and apoptosis.

Authors:  Hanjie Yu; Mingxiu Li; Xiaodong Wen; Jie Yang; Xiaojun Liang; Xia Li; Xiaojuan Bao; Jian Shu; Xiameng Ren; Wentian Chen; Zheng Li; Yi Li
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

Review 2.  O-GlcNAcylation: a bridge between glucose and cell differentiation.

Authors:  Chao Sun; Jin Shang; Yuan Yao; Xiaohong Yin; Minghan Liu; Huan Liu; Yue Zhou
Journal:  J Cell Mol Med       Date:  2016-03-01       Impact factor: 5.310

3.  Mechanical stress alters protein O-GlcNAc in human periodontal ligament cells.

Authors:  Dorottya Frank; Annamária Cser; Béla Kolarovszki; Nelli Farkas; Attila Miseta; Tamás Nagy
Journal:  J Cell Mol Med       Date:  2019-06-25       Impact factor: 5.310

4.  Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis.

Authors:  Sabine Trellu; Alice Courties; Stéphane Jaisson; Laëtitia Gorisse; Philippe Gillery; Saadia Kerdine-Römer; Carlos Vaamonde-Garcia; Xavier Houard; François-Paul Ekhirch; Alain Sautet; Bertrand Friguet; Claire Jacques; Francis Berenbaum; Jérémie Sellam
Journal:  Arthritis Res Ther       Date:  2019-01-11       Impact factor: 5.156

5.  Glucose regulates tissue-specific chondro-osteogenic differentiation of human cartilage endplate stem cells via O-GlcNAcylation of Sox9 and Runx2.

Authors:  Chao Sun; Weiren Lan; Bin Li; Rui Zuo; Hui Xing; Minghan Liu; Jie Li; Yuan Yao; Junlong Wu; Yu Tang; Huan Liu; Yue Zhou
Journal:  Stem Cell Res Ther       Date:  2019-11-28       Impact factor: 6.832

Review 6.  Glucosamine as a Treatment for Osteoarthritis: What If It's True?

Authors:  Thierry Conrozier; Thomas Lohse
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

7.  The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.

Authors:  Jana Riegger; Julia Baumert; Frank Zaucke; Rolf E Brenner
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

8.  Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro.

Authors:  Trine M Reine; Trond Geir Jenssen; Svein Olav Kolset
Journal:  Food Nutr Res       Date:  2016-09-23       Impact factor: 3.894

9.  Detection of O-Linked-N-Acetylglucosamine Modification and Its Associated Enzymes in Human Degenerated Intervertebral Discs.

Authors:  Georgios Nikolaou; Aristeidis H Zibis; Apostolos H Fyllos; Antonios Katsioulis; Sotirios Sotiriou; Anastasios Kotrotsios; Markos Sgantzos; Aikaterini Vassiou; Dimitrios L Arvanitis
Journal:  Asian Spine J       Date:  2017-12-07

10.  Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis.

Authors:  Villő Muha; Florence Authier; Zsombor Szoke-Kovacs; Sara Johnson; Jennifer Gallagher; Alison McNeilly; Rory J McCrimmon; Lydia Teboul; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2021-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.